ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,792, issued on July 22, was assigned to Foundry Therapeutics Inc. (Menlo Park, Calif.).

"Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents" was invented by Karun D. Naga (Los Altos, Calif.), Stephen W. Boyd (San Francisco), Hanson S. Gifford III (Woodside, Calif.), Mark Deem (Portola Valley, Calif.), John Morriss (Emerald Hills, Calif.), Martin Mayse (Wayzata, Minn.), Honglei Wang (Singapore), Jingnan Luo (Singapore), Daniel Boon Lim Seet (Singapore), Koon Kiat Teu (Singapore) and Wei Li Lee (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The devices, systems, and methods disclosed...